If you are:
FDB Only When Necessary: AVAILABLE DATA SUGGEST LITTLE OR NO KNOWN RISK FOR DEVELOPMENTAL TOXICITY
No Known Risk: HUMAN DATA INDICATE NO KNOWN ADVERSE EFFECT ON NURSING INFANT
An adult over 60:
management or monitoring precaution: Neuro/Psych-The Women's Health Initiative Memory Study demonstrated an increased relative risk (2.05, 95% CI) of probable dementia in the elderly when used in combination with estrogens.
Giving medroxyprogesterone ACETATE Vial to a child under 12:
Severe Precaution: Not indicated before menarche. May affect bone development/density.
Severe Precaution: No safety and efficacy for use in endometrial or renal carcinoma. Reduces bone mineral density.